Inventor · disambiguated record
Stephan Grupp
Also filed as: GRUPP STEPHAN · GRUPP STEPHAN A
3 granted patents·8 pending applications·33 citations·filing 2002–2024
71Inventor score
Files withNOVARTIS AG4UNIV PENNSYLVANIA4PHILADELPHIA CHILDREN HOSPITAL1THE CHILDREN'S HOSPITAL OF PHILADELPHIA1
Top patents by PatentIndex Score
11 records- 0195US10603378B2Toxicity management for anti-tumor activity of CARsUNIV PENNSYLVANIA·Filed 2018·Granted Mar 31, 2020·10 cites·28 claims
- 0292US11273219B2Toxicity management for anti-tumor activity of CARsUNIV PENNSYLVANIA·Filed 2018·Granted Mar 15, 2022·4 cites·20 claims
- 0377US7026330B2Methods for treatment of acute lymphocytic leukemiaPHILADELPHIA CHILDREN HOSPITAL·Filed 2003·Granted Apr 11, 2006·19 cites·11 claims
- 0475US2023013642A1Toxicity Management for Anti-Tumor Activity of CARsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0570US2024408206A1Compositions and methods for treating b-lymphoid malignanciesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0658US2015202286A1Toxicity Management for Anti-Tumor Activity of CARsUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 0749US2022047633A1Cd22 chimeric antigen receptor (car) therapiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0847US2020085869A1Therapeutic regimens for chimeric antigen receptor therapiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0944US2017239294A1Compositions and methods for treating b-lymphoid malignanciesTHE CHILDREN'S HOSPITAL OF PHILADELPHIA·Filed 2015·Application pending·0 cites
- 1042US2003100605A1Methods of treating cancer with angiogenesis inhibitorsFiled 2002·Application pending·0 cites
- 1139US2019151365A1Combination therapies of chimeric antigen receptors and pd-1 inhibitorsNOVARTIS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephan Grupp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →